Objectives Our study aimed to determine the frequency of sick euthyroid syndrome (SES) 
Introduction

Sick euthyroid syndrome (SES) is characterized by alterations in the levels of thyroid hormones due to non-thyroidal diseases, in the absence of any disorder related to hypothalamic-hypophysial axis or thyroid gland (1). The most common hormone pattern in this syndrome is a decrease in serum free triiodothyronine (fT3) level accompanied by normal thyroxine (T4) and thyrotropin (TSH) levels (2). Although it is suggested that SES results from a decrease in the deiodinase enzyme responsible for conversion of T4 to T3 in peripheral tissues, the real underlying pathogenesis is not fully understood (2). SES has been observed in almost all serious medical conditions including malnutrition, sepsis, liver disease, renal failure, trauma, uncontrolled diabetes, and malignancy;it is also reported that the presence of SES is associated with the gravity of the underlying disease and the nutritional state of the patients, and that is increases mortality (3-5). The prognosis for the patients with non-small cell lung cancer (NSCLC) is related to the stage of the disease. Moreover, cell type, proliferate fraction and DNA content of the tumor, gender, nutritional and psychological state of the patient are other factors affecting the prognosis. A few studies showing that SES is observed in cancer sufferers and that prognosis is poorer for these patients have been published
.
In the present study, we aimed to determine the frequency of SES, to identify its relation with the Karnofsky index (KI) (12, 13) .
Tumor staging: Cases with NSCLC were staged by using the TNM system proposed by "American Joint Committee on Cancer" (14) . Positron (19, 20 (8, (23) (24) (25) (26) (27) (28) (24) . In a study including subjects with chronic heart failure, SES cases were found to have a higher mortality rate during follow-up period (28) (29) . Several studies demonstrating the presence of SES in malignant diseases and its association with poor prognosis have been published (6, 7, 25 It is known that, through the aging process, functional and structural alterations occur in the hypothalamus, hypophyseal and thyroid glands (31) . Bossoni et al detected a high incidence of SES in elderly subjects (31) . Although the subjects in the present study were aged in general, no relation was recognized between SES and age.
T a b l e 1 . S E S I n c i d e n c e Ac c o r d i n g t o S t a g e s T a b l e 2 . Co mp a r i s o n o f Di f f e r e n t P a r a me t e r s Ac c o r d i n g t o t h e P r e s e n c e o f S E S were detected significantly lower in cases with SES in comparison to cases without SES (
In SES, this later process is weakened although T3 production in the thyroid gland is normal. It is estimated that low plasma T3 concentration is mainly the result of a decrease in peripheral deiodination of T4 (1). It is still debated whether it is a physiologic response to underlying disease or an impaired adaptation mechanism. Nevertheless, the pathogenesis of SES is not fully understood. This ignorance about the pathophysiology of SES led to a number of studies in this field (9, 15). These studies focused on the role of cytokines in the development of SES. In particular, interleukin (IL)-1, IL-6, tumor necrosis factor (TNF)-α and interferon-β are thought to participate in this process. It was demonstrated that these cytokines inhibit the enzyme 5-deiodinase responsible for the conversion of T4 into T3 in peripheral tissues (15). Feelders et al detected oncology patients with SES had higher TNF-α and IL-6 levels compared to those without SES (9). We could not measure any cytokine level. But we count the number of leucocytes and thrombocytes which possibly associated with inflammatory cytokines. Although there was no any patient with massive leucocytosis or thrombocytosis, a slight correlation was found between the presence of SES and count of thrombocytes. Several studies described the presence of SES in pulmonary diseases and malignancies (16, 17). Stage of malignant
F i g u r e 1 . S u r v i v a l c u r v e s o f NS CL C p a t i e n t s wi t h a n d wi t h o u t S E S . NS CL C: n o n -s ma l l c e l l l u n g c a n c e r , S E S : s i c k e u t h y r o i d s y n d r o me . diseases and severity affects thyroid function tests. Chow et al reported a 63% incidence of SES in 40 pulmonary TB patients (16). Wawrzynska et al found out in their survey that SES is frequent in patients with severe respiratory failure requiring intensive care (17). Tellini et al investigated thyroid hormone levels in 220 cases with malignancy in different organs and found out SES in 58% of the patients (6). Vexiau et al reported the incidence of SES in 220 cases with hematological malignancies as 37% (7). Wehmann et al found SES incidence as 54% in a similar group of patients (8). As a result of our study, we determined SES in 35% of cases with NSCLC. This result is less than what was found by Tellini et al (58%) but comparable to that of Vexiau et al (37%) (6, 7). However, these studies did not include lung cancer patients and we could not find any other studies using with lung cancer patients in the medical literature (Medline, 1996-2006). The essential characteristics of SES are a decrease in fT3 alone or in fT3 and fT4 together, with a TSH level within or below normal limits (18). Among our 28 SES cases, 22 (79%) had only decreased fT3 (type 1), 6 (21%) had decreased fT3 and fT4 levels (type 2). SES type 1 which is characterized by exclusively decreased fT3 levels is the most common type according to literature, as justified by our data. It was reported that TSH levels were normal or just below normal in 80% of SES patients but significantly decreased in 10%, and that prognosis was poorer in the later
In conclusion, we determined that SES may be frequently seen in cases with NSCLC. Furthermore, the presence of SES can be used as an indicator defining the severity of the illness and predicting the prognosis of NSCLC patients.
